Trial intelligence / Profile preview

High-dose versus low-dose nortriptyline for radiculopathic leg pain

ACTRN12612001304820Phase 4Not yet recruiting

Sponsor
Wellington Hospital
Start
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, triple-blind trial of nortriptyline in radiculalgia (2 arms), sponsored by Wellington Hospital. Primary endpoint: Pain at 12 weeks. Planned start Dec 2012; status: not yet recruiting.

02

Drugs

nortriptyline
03

Conditions

radiculalgia

Beyond the preview

Go deeper on ACTRN12612001304820.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12612001304820.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call